115 filings
Page 3 of 6
6-K
0hd8hisaov
31 Jul 23
Incannex Provides Access to Financial Advisory Firm to Shareholders for Advice Pertaining to Transition from ASX to Nasdaq
7:34pm
6-K
hzcafzgpvai4
27 Jul 23
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
8:47pm
6-K
hgt7ri6
25 Jul 23
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
9:42pm
6-K
odh d9yh902bcg1
20 Jul 23
Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea
9:47pm
6-K
82dx qk4i4yk0x5jhm
18 Jul 23
Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep Apnoea
6:04am
6-K
bk0dk
13 Jul 23
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
6:02am
6-K
s8dy4jd j2vho1
10 Jul 23
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq
8:43am
6-K
g3ixowg5ek m8
5 Jul 23
Report of Foreign Private Issuer
8:47pm
6-K
69gvn3jm70
30 Jun 23
Report of Foreign Private Issuer
8:00am
6-K
sz9n9o
22 Jun 23
Incannex Announces Participation at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference
8:05pm
6-K
o9mcyz
15 Jun 23
Incannex Appoints Principal Investigators for IHL-42X Phase 2/3 Clinical Trial
9:06pm
6-K
t77yy
7 Jun 23
Report of Foreign Private Issuer
8:00am
6-K
pzfhthn
30 May 23
Report of Foreign Private Issuer
8:02am
6-K
ozhjq1h
30 May 23
Entitlement Offer of Loyalty Options
8:00am
6-K
ahaqiwp
18 May 23
Report of Foreign Private Issuer
8:00am
6-K
6d2c59oq
5 May 23
Report of Foreign Private Issuer
6:06am
6-K
g7e 57k5jhc52s
3 May 23
Report of Foreign Private Issuer
6:05am
6-K
xnk4b
2 May 23
Incannex Announces Final Results from Phase 1 Clinical Trial Assessing Safety and Pharmacokinetics of IHL-675A
12:00am
6-K
hr7ta
26 Apr 23
Incannex Healthcare March 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
9:40pm
6-K
khkyjgceq
13 Apr 23
Incannex Appoints QPS to Advance CannQuit-N™ (Nicotine), CannQuit-O™ (Opioid) and Renecann™ Products in the USA and EU
9:23pm